PEN News and Press, Penumbra Inc. From 01/15/26

A look at the top 10 most actives in the United States Agape ATP Corporation (ATPC) rose 57.6% to $0.1103 on volume of 485,919,266 shares Mingteng International Corporation Inc. (MTEN) fell 7.4% to $0.03269 on volume of 445,540,698 shares Oriental Culture Holding LTD (OCG) fell 14.0% to $0....

2026-01-15 13:45:55 ET Introduction Boston Scientific Corporation ( BSX ) is in the news this morning because it entered into a definitive agreement to acquire Penumbra ( PEN ) for around $14.5B in a cash and stock transaction, which is expected to be closed this yea...

2026-01-15 12:10:25 ET Already one of the best growth stories in med-tech, Boston Scientific ( BSX ) has once again turned to M&A to not only bolster its growth profile but also fill one of the relatively few obvious gaps in the portfolio. Acquiring Penumbra ( PEN ) will be ...

2026-01-15 09:59:44 ET Penumbra, Inc. (NYSE: PEN) is one of today’s top gainers. The company’s shares have moved 12.15% on the day to $351.5. Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The compa...

2026-01-15 09:27:48 ET Markets Wake Up to Execution, Scale, and Strategic M&A Denver, Colorado- This morning’s market narrative is defined by a common thread: companies that have moved beyond vision and into execution are commanding attention. Callan JMB (NASDAQ:CJM...

Shareholders should contact the firm as there may be limited time to enforce your rights. Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Penumbra, Inc. (NYSE: PEN) to Boston Scientific Corporation for $374.00 in cash or 3.8721 shares of Boston Sc...

2026-01-15 07:37:08 ET More on Boston Scientific, Penumbra Boston Scientific Corporation (BSX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Penumbra, Inc. (PEN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Boston Scient...

Boston Scientific announces agreement to acquire Penumbra, Inc. PR Newswire Acquisition to expand Boston Scientific's cardiovascular portfolio and further address increasing prevalence of vascular diseases Provides scaled entry into mechanical thrombectomy and neurovascular, ke...

Penumbra, Inc. Provides Preliminary Update on Fourth Quarter and Full Year 2025 Financial Results PR Newswire ALAMEDA, Calif. , Jan. 15, 2026 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today announced certain unaudited and preliminar...

2026-01-14 15:29:16 ET More on Penumbra Penumbra, Inc. (PEN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Penumbra: Well-Placed For Above-Average Growth, But Mind The Volatility Penumbra, Inc. (PEN) Presents at Piper Sandler 37th Annual Health...